Literature DB >> 3439914

Development of cis-platinum-induced hearing loss in guinea pigs.

L J Hoeve1, E A Conijn, I R Mertens zur Borg, M Rodenburg.   

Abstract

The resultant hearing loss can be variable if cis-dichlorodiammineplatinum is given to guinea pigs. In order to find out more about these differences, we used brainstem audiometry to study the start and development of hearing loss over time for several frequencies. Our results confirmed previous observations that hearing loss starts at the higher frequencies but can also occur at lower frequencies. Furthermore, there were great differences in the start and the rate of the increase of hearing loss found in the individual animals. The individual differences in susceptibility can not be explained by one factor alone, but by the combination of three factors, namely deviation point, slope and length of survival.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3439914     DOI: 10.1007/BF00468633

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  11 in total

1.  Ototoxicity of cis-dichlorodiammine platinum (II) in the guinea pig.

Authors:  R W Fleischman; S W Stadnicki; M F Ethier; U Schaeppi
Journal:  Toxicol Appl Pharmacol       Date:  1975-08       Impact factor: 4.219

2.  INHIBITION OF CELL DIVISION IN ESCHERICHIA COLI BY ELECTROLYSIS PRODUCTS FROM A PLATINUM ELECTRODE.

Authors:  B ROSENBERG; L VANCAMP; T KRIGAS
Journal:  Nature       Date:  1965-02-13       Impact factor: 49.962

Review 3.  Toxic effects of cis-dichlorodiammineplatinum(II) in man.

Authors:  D D Von Hoff; R Schilsky; C M Reichert; R L Reddick; M Rozencweig; R C Young; F M Muggia
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

4.  Effects of cis-diamminedichloroplatinum (NSC-119875) on hearing function in man.

Authors:  I J Piel; D Meyer; C P Perlia; V I Wolfe
Journal:  Cancer Chemother Rep       Date:  1974 Nov-Dec

5.  Platinum compounds: a new class of potent antitumour agents.

Authors:  B Rosenberg; L VanCamp; J E Trosko; V H Mansour
Journal:  Nature       Date:  1969-04-26       Impact factor: 49.962

6.  Treatment of genitourinary tumours with cis-dichlorodiammineplatinum(II): experience in 250 patients.

Authors:  C E Merrin
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

7.  Pathophysiology of the ototoxicity of cis-diamminedichloroplatinum.

Authors:  S Komune; S Asakuma; J B Snow
Journal:  Otolaryngol Head Neck Surg       Date:  1981 Mar-Apr       Impact factor: 3.497

8.  cis-Dichlorodiammineplatinum(II) in non-small cell carcinoma of the lung.

Authors:  R J Gralla; E Cvitkovic; R B Golbey
Journal:  Cancer Treat Rep       Date:  1979 Sep-Oct

9.  Analysis of hearing loss due to cis-diamminedichloroplatinum-II.

Authors:  L G van Zeijl; E A Conijn; M Rodenburg; R A Tange; M P Brocaar
Journal:  Arch Otorhinolaryngol       Date:  1984

10.  Ototoxicity of cis-diamminedichloroplatinum (II): influence of dose, schedule and mode of administration.

Authors:  J B Vermorken; T S Kapteijn; A A Hart; H M Pinedo
Journal:  Eur J Cancer Clin Oncol       Date:  1983-01
View more
  1 in total

1.  Correlations between cis-platinum dosage and toxicity in a guinea pig model.

Authors:  L J Hoeve; I R Mertens zur Borg; M Rodenburg; M P Brocaar; B G Groen
Journal:  Arch Otorhinolaryngol       Date:  1988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.